i was thinking ...
always a concern huh
maybe CB is getting some early results back on Starlite and other therapies
whilst TLX doesn't need the $650M, maybe he's thinking it's well worth investing further and deeper as the early results are so impressive
maybe
maybe not ?
i note from the presentation release.
whilst its not new information, it hasn't been in past few presentations
TLX591: Highly differentiated PSMA targeting therapyFirst-in-class / best-in-class radiopharmaceutical therapy using a biologic
Promising overall survivaldemonstrated in early studiesMedian OS 42.3 months1
More effective treatment allows patientsto live longerImproved payor treatment cost-effectiveness
Ann: Telix Successfully Prices A$650M Convertible Bonds, page-63
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$22.86 |
Change
0.000(0.00%) |
Mkt cap ! $7.650B | |||
| Open | High | Low | Value | Volume |
| $23.21 | $23.42 | $21.50 | $24.35M | 1.067M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 438 | $22.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $22.87 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| TLX (ASX) Chart |